MINI FUTURE LONG - NOVONESIS B Share Price

Certificat

DE000MG30LY1

Delayed Börse Stuttgart 16:38:30 29/05/2024 BST
0.86 EUR -20.37% Intraday chart for MINI FUTURE LONG - NOVONESIS B
Current month+116.00%
1 month+92.86%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
29/05/24 0.86 -20.37%
28/05/24 1.08 -2.70%
27/05/24 1.11 +8.82%
24/05/24 1.02 +2.00%
23/05/24 1 -13.04%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 04:38 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVONESIS A/S
Issuer Morgan Stanley
WKN MG30LY
ISINDE000MG30LY1
Date issued 25/04/2024
Strike 348.6 kr
Maturity Unlimited
Parity 10 : 1
Emission price 0.6
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.18
Lowest since issue 0.48
Spread 0.01
Spread %1.09%

Company Profile

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Sector
-
More about the company

Ratings for Novonesis A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Novonesis A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
421.9 DKK
Average target price
437.4 DKK
Spread / Average Target
+3.67%
Consensus